MAPT and Alzheimer disease: In the case of AD, which is characterized by a gradual decline typically in memory and cognitive function due to neuronal degeneration, symptom severity is associated with cerebral cortex protein aggregations, such as β-amyloid (Aβ) plaques, and particularly hyperphosphorylated Tau protein [12,13] leading to the formation of neurofibrillary tangles.